About Opioid growth factor receptor-like protein 1
Opioid growth factor receptor-like protein 1 (OGFRL1) is a protein
from Homo sapiens identified by UniProt accession
Q5TC84, 451 residues long.
MolForge cross-references it against 0 known binders and
38 disease associations.
Target properties
| Protein name | Opioid growth factor receptor-like protein 1 |
| UniProt accession | Q5TC84 |
| Gene | OGFRL1 |
| Organism | Homo sapiens |
| Length | 451 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (38)
Diseases linked to this target (Open Targets).
- body height · score 0.34
- heel bone mineral density · score 0.30
- manic or hypomanic episode · score 0.29
- diastolic blood pressure · score 0.28
- hypertension · score 0.25
- blood phosphate measurement · score 0.22
- forced expiratory volume · score 0.10
- sitting height measurement · score 0.08
- coronary artery disease · score 0.08
- stroke · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5TC84-F1 | alphafold | PREDICTED | 70.80 | — |
Amino-acid sequence (451 residues)
MGNLLGGVSF REPTTVEDCD STWQTDSEPE PEEPGPGGGS EGPGQESEQP AQPPEQAGGR PGASPAPDED AEAAGAEQGG DSTEATAKPK RSFYAARDLY KYRHQYPNFK DIRYQNDLSN LRFYKNKIPF KPDGVYIEEV LSKWKGDYEK LEHNHTYIQW LFPLREQGLN FYAKELTTYE IEEFKKTKEA IRRFLLAYKM MLEFFGIKLT DKTGNVARAV NWQERFQHLN ESQHNYLRIT RILKSLGELG YESFKSPLVK FILHEALVEN TIPNIKQSAL EYFVYTIRDR RERRKLLRFA QKHYTPSENF IWGPPRKEQS EGSKAQKMSS PLASSHNSQT SMHKKAKDSK NSSSAVHLNS KTAEDKKVAP KEPVEETDRP SPEPSNEAAK PRNTEKDSNA ENMNSQPEKT VTTPTEKKES VSPENNEEGG NDNQDNENPG NTNCHDVVLV Q
Explore Opioid growth factor receptor-like protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets